Workman P, Twentyman P R
Br J Cancer. 1982 Aug;46(2):249-59. doi: 10.1038/bjc.1982.190.
Using a regrowth-delay assay, we investigated structure/activity relationships for the enhancement by electron-affinic agents of the anti-tumour effect of the nitrosourea CCNU against the KHT sarcoma in C3H mice. A series of neutral 2-nitroimidazoles similar in electron affinity but varying in octanol/water partition coefficient (PC) over 4 orders of magnitude (0.016- greater than 200, Misonidazole = 0.43) were examined at a fixed dose of 2.5 mmol/kg. A parabolic (quadratic) dependence of activity on log PC was observed. Analogues more hydrophilic than misonidazole (MISO) were inactive as were those with very high PCs (greater than 20). Those with PC 0.43--20 were usually more active than MISO, some considerably so. The fairly lipophilic 5-nitroimidazoles nimorazole and metronidazole (METRO) had similar activity to MISO, despite their reduced electron affinity. Two basic 2-nitroimidazoles more efficient as radiosensitizers in vitro likewise showed activity comparable to MISO. We also investigated several agents more electron-affinic than MISO, including some non-nitro compounds. Most were inactive at maximum tolerated doses, but nitrofurazone showed reasonable activity. Sensitizer dose-response curves were obtained for MISO, METRO and two of the most effective agents, benznidazole (Ro 07-1051) and Ro 07-1902. The two latter agents were both considerably more active than MISO at low doses (0.1--0.9 mmol/kg). These studies indicate that the structural features of electron-affinic agents responsible for the enhancement of KHT tumour response to CCNU, are quite different from those affecting radiosensitization, lipophilicity being particularly important. The microsomal enzyme-inhibitor SKF 525A increased the anti-tumour effect of CCNU, suggesting inhibition of CCNU metabolism as one possible mechanism contributing to chemosensitization by lipophilic electron-affinic agents in mice.
我们采用再生延迟试验,研究了亲电子试剂增强亚硝基脲洛莫司汀(CCNU)对C3H小鼠KHT肉瘤抗肿瘤作用的构效关系。研究了一系列电子亲和力相似但辛醇/水分配系数(PC)相差4个数量级(0.016至大于200,米索硝唑=0.43)的中性2-硝基咪唑,固定剂量为2.5 mmol/kg。观察到活性与log PC呈抛物线(二次)关系。比米索硝唑(MISO)更亲水的类似物无活性,PC值非常高(大于20)的类似物也无活性。PC值为0.43至20的类似物通常比MISO更具活性,有些活性相当显著。相当亲脂的5-硝基咪唑尼莫唑和甲硝唑(METRO)尽管电子亲和力降低,但活性与MISO相似。两种在体外作为放射增敏剂更有效的碱性2-硝基咪唑同样显示出与MISO相当的活性。我们还研究了几种比MISO亲电子性更强的试剂,包括一些非硝基化合物。大多数在最大耐受剂量下无活性,但呋喃西林显示出合理的活性。获得了MISO、METRO以及两种最有效的试剂苯硝唑(Ro 07-1051)和Ro 07-1902的增敏剂剂量反应曲线。后两种试剂在低剂量(0.1至0.9 mmol/kg)时均比MISO活性高得多。这些研究表明,亲电子试剂增强KHT肿瘤对CCNU反应的结构特征与影响放射增敏的结构特征有很大不同,亲脂性尤为重要。微粒体酶抑制剂SKF 525A增强了CCNU的抗肿瘤作用,表明抑制CCNU代谢是亲脂性亲电子试剂在小鼠中产生化学增敏作用的一种可能机制。